Umoja Biopharma is a game-changing biotech start-up with locations in Seattle, WA and Boulder, CO, focused on transforming the treatment of cancer with a novel integrated immunotherapy platform. Our vision is to develop off-the-shelf therapies capable of treating any tumor, any time. We are a diverse and growing team working in brand-new facilities in downtown Seattle, Washington, and Boulder, Colorado, and we are looking for innovative thinkers who are excited by groundbreaking science and technology, and passionate about squaring up to the challenges inherent to cutting edge drug development. We are committed to the principles of Diversity Equity and Inclusion and strongly invite applications from enthusiastic individuals who share our commitment and help position Umoja as a leader in this front. 

We at Umoja believe in the importance of stories; we are looking for great people to join our team to help us create more stories for ourselves, for you, and most importantly for patients and their families.  

Umoja Biopharma – Your Body. Your Hope. Your Cure.  


Umoja is looking for a driven Analytical Senior Scientist to drive strategy, knowledge and deliverables related to developing lentiviral vector analytics. The candidate should have an in-depth understanding of vector biology (Lenti, AAV, etc.) and engineered T cell therapies and will partner with leadership to shape analytical strategies that support development of Umoja’s drug products. The candidate will play a leadership role within Analytical Development and should have experience in developing analytical methods, including bringing in new technology, troubleshooting, and assay qualification to support regulatory submissions. The ideal candidate has a proven track record in analytical method design and testing, molecular virology, and automation. The position will be accountable for the analytical strategy that spans the development of analytical methods related to the strength and identity of drug candidates. Experience in method transfer to internal teams and external partners is desired.  

The final level of this position will be based on the candidate’s qualifications. 

Specific responsibilities include: 

  • Lead scientists and research associates within analytical development, providing technical oversight 
  • Lead the successful design, execution, analysis, and documentation of experiments to develop analytical methods for lentiviral vectors
  • Perform experiments to support analytical development and product characterization using advanced techniques including qPCR/ddPCR, ELISAs, Western blots, virus particle characterization, and multicolor flow cytometry
  • Automation of analytical methods
  • Oversee the qualification of analytical methods
  • Supports creating and maintenance of an analytical lab including equipment and hiring
  • Drive bringing in new technology in analytical development to support business objectives
  • Foster good teamwork and communication. Build a reputation of excellence as an individual and as a team
  • Author, review and approve technical documents including standard operating procedures, test methods, and technical reports
  • Present findings on method development and provide interpretation and strategic plans related to the development of analytical methods to cross-functional teams 

The successful candidate will have: 

  • At the Senior Scientist level: PhD/MS/BS in Molecular Biology or Immunology or relevant field with 2/5/10+ years of experience respectively 
  • At the Principal Scientist level: PhD/MS/BS in Molecular Biology or Immunology or relevant field with 5/10/12+ years of experience respectively  
  • Proven track record in method development, including experimental design, execution, and statistical analysis of results  
  • Experience qualifying and transferring analytical methods to a QC or external laboratory 
  • Experience with qPCR/ddPCR, multicolor flow cytometry and analysis software, cell-based assays, ELISAs, Westerns, and viral transduction 

Preferred Qualifications: 

  • Experience with GxP, ICH, and FDA regulations as they apply to release testing is preferred 
  • Ability to work in a fast-paced environment with broad responsibilities, meet deadlines, and prioritize work on multiple projects  
  • Strong communication skills in technical writing and oral presentation. Respectful of others and open to new ideas. 

Physical Requirements: 

  • Ability to wear personal protective equipment (PPE) including gloves, protective clothing, and eye safety glasses 
  • Perform physical tasks including standing, use of hand, walk, bend, kneel, sit, and occasionally move materials up to 50 pounds 

COVID-19 Policy

Pursuant to Umoja Biopharma’s Vaccine Policy, we are currently requiring all employees to be fully vaccinated to work onsite or visit any of our physical locations. In addition, you must provide proof of vaccination to work onsite or visit any of our physical locations. Umoja will consider reasonable accommodation for medical condition/disability and sincerely held religious belief, practice or observance unless such accommodation would result in an undue hardship.

Benefits Offerings

Umoja Biopharma offers its employees comprehensive Medical, Dental, and Vision plans through Premera Blue Cross, Delta Dental, and VSP, respectively, with no premium costs to our employees. Additionally, we offer Umojians access to a 401k plan through Fidelity, with a 100% match up to their first 6% deferral. Umoja also provides a competitive, unlimited Paid Time Off policy, employee commuter benefits, and childcare reimbursement. For a full breakdown of our benefits offerings, please see the Benefits section of our website.

Apply for this Job

* Required
resume chosen  
(File types: pdf, doc, docx, txt, rtf)
cover_letter chosen  
(File types: pdf, doc, docx, txt, rtf)

Voluntary Self-Identification

For government reporting purposes, we ask candidates to respond to the below self-identification survey. Completion of the form is entirely voluntary. Whatever your decision, it will not be considered in the hiring process or thereafter. Any information that you do provide will be recorded and maintained in a confidential file.

As set forth in Umoja Biopharma’s Equal Employment Opportunity policy, we do not discriminate on the basis of any protected group status under any applicable law.

Race & Ethnicity Definitions

If you believe you belong to any of the categories of protected veterans listed below, please indicate by making the appropriate selection. As a government contractor subject to the Vietnam Era Veterans Readjustment Assistance Act (VEVRAA), we request this information in order to measure the effectiveness of the outreach and positive recruitment efforts we undertake pursuant to VEVRAA. Classification of protected categories is as follows:

A "disabled veteran" is one of the following: a veteran of the U.S. military, ground, naval or air service who is entitled to compensation (or who but for the receipt of military retired pay would be entitled to compensation) under laws administered by the Secretary of Veterans Affairs; or a person who was discharged or released from active duty because of a service-connected disability.

A "recently separated veteran" means any veteran during the three-year period beginning on the date of such veteran's discharge or release from active duty in the U.S. military, ground, naval, or air service.

An "active duty wartime or campaign badge veteran" means a veteran who served on active duty in the U.S. military, ground, naval or air service during a war, or in a campaign or expedition for which a campaign badge has been authorized under the laws administered by the Department of Defense.

An "Armed forces service medal veteran" means a veteran who, while serving on active duty in the U.S. military, ground, naval or air service, participated in a United States military operation for which an Armed Forces service medal was awarded pursuant to Executive Order 12985.

Form CC-305

OMB Control Number 1250-0005

Expires 05/31/2023

Voluntary Self-Identification of Disability

Why are you being asked to complete this form?

We are a federal contractor or subcontractor required by law to provide equal employment opportunity to qualified people with disabilities. We are also required to measure our progress toward having at least 7% of our workforce be individuals with disabilities. To do this, we must ask applicants and employees if they have a disability or have ever had a disability. Because a person may become disabled at any time, we ask all of our employees to update their information at least every five years.

Identifying yourself as an individual with a disability is voluntary, and we hope that you will choose to do so. Your answer will be maintained confidentially and not be seen by selecting officials or anyone else involved in making personnel decisions. Completing the form will not negatively impact you in any way, regardless of whether you have self-identified in the past. For more information about this form or the equal employment obligations of federal contractors under Section 503 of the Rehabilitation Act, visit the U.S. Department of Labor’s Office of Federal Contract Compliance Programs (OFCCP) website at

How do you know if you have a disability?

You are considered to have a disability if you have a physical or mental impairment or medical condition that substantially limits a major life activity, or if you have a history or record of such an impairment or medical condition.

Disabilities include, but are not limited to:

  • Autism
  • Autoimmune disorder, for example, lupus, fibromyalgia, rheumatoid arthritis, or HIV/AIDS
  • Blind or low vision
  • Cancer
  • Cardiovascular or heart disease
  • Celiac disease
  • Cerebral palsy
  • Deaf or hard of hearing
  • Depression or anxiety
  • Diabetes
  • Epilepsy
  • Gastrointestinal disorders, for example, Crohn's Disease, or irritable bowel syndrome
  • Intellectual disability
  • Missing limbs or partially missing limbs
  • Nervous system condition for example, migraine headaches, Parkinson’s disease, or Multiple sclerosis (MS)
  • Psychiatric condition, for example, bipolar disorder, schizophrenia, PTSD, or major depression

PUBLIC BURDEN STATEMENT: According to the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless such collection displays a valid OMB control number. This survey should take about 5 minutes to complete.